Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 954-961

  Hunger, Robert E ^a   Müller, Stefan ^a   Laissue, Jean A ^a   Hess, Max W ^a   Carnaud, Claude ^b   Garcia, Irene ^c   Mueller, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

autoimmune diseases; cell adhesion molecules; sialadenitis; Sjogren's syndrome; tumor necrosis factor

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G3; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CONTROLLED STUDY; ETIOLOGY; FEMALE; GENE EXPRESSION REGULATION; INHIBITION KINETICS; LACRIMAL GLAND; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SPECIES DIFFERENCE; SUBMANDIBULAR GLAND;

EID: 0029832264     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118879     Document Type: Article

References (28)

1. Pozzilli, P., A. Signore, A.J. Williams, and P.E. Beales. 1993. NOD mouse colonies around the world - recent facts and figures. Immunol. Today. 14:193-196.
2. Jabs, D.A., and R.A. Prendergast. 1994. Murine models of Sjogren's syndrome. Adv. Exp. Med. Biol. 350:623-630.
3. Humphreys Beher, M.G., Y. Hu, Y. Nakagawa, P.L. Wang, and K.R. Purushotham. 1994. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome. Adv. Exp. Med. Biol. 350:631-636.
4. Goillot, E., M. Mutin, and J.L. Touraine. 1991. Sialadenitis in nonobese diabetic mice: transfer into syngeneic healthy neonates by splenic T lymphocytes. Clin. Immunol. Immunopathol. 59:462-473.
5. Miyagawa, J., T. Hanafusa, A. Miyazaki, K. Yamada, H. Fujino-Kurihara, H. Nakajima, N. Kono, K. Nonaka, Y. Tochino, and S. Tarui. 1986. Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse. Virchows Arch. 51:215-225.
6. Sugihara, T., Y. Yoshimura, and O. Tanaka. 1989. Ultrastructural and immunoelectron microscopic studies on infiltrating mononuclear cells in lymphocytic submandibulitis in NOD mice. Histol. Histopath. 4:397-404.
7. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
8. Sikorski, E.E., R. Hallmann, E.L. Berg, and E.C. Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-α and IL-1. J. Immunol. 151:5239-5250.
9. Pukel, C., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin and interleukin-1. Diabetes. 37:133-136.
10. Cleveland, J.L., and J.N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell. 81:479-482.
11. Jacob, CO., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin1. Proc. Natl. Acad. Sci. USA. 87:968-972.
12. Yang, X.D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
13. Jacob, CO., S. Aiso, R.D. Schreiber, and H.O. McDevitt. 1992. Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int. Immunol. 4: 611-614.
14. Garcia, I., Y. Miyazaki, M. Araki, R. Lucas, G.E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J Immunol. 25:2401-2407.
15. Wicker, L.S., J. A. Todd, and L.B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200.
16. Flaherty, L. 1981. Congenic strains. In The Mouse in Biomedical Research. Vol. 1. H.L. Foster, J.D. Small, and J.G. Fox, editors. Academic Press, Inc., Orlando, FL. 215-222.
17. Sepulveda, A.R., M.J. Finegold, B. Smith, B.L. Slagle, J.L. DeMayo, R.F. Shen, S L.C. Woo, and J.S. Butel. 1989. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res. 49:6108-6117.
18. Hogan, M.M., and S.N. Vogel. 1993. Measurement of tumor necrosis factor α and β. In Current Protocols in Immunology. Vol. 1. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley and Sons. Inc., New York. 6.10.1-6.10.5.
19. Pennica, D., J.L. Hayflick, T.S. Bringman, M.A. Pallading, and D.V. Goeddel. 1985. Cloning and expression in Escherichia coli of the DNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 82:6060-6064.
20. Mueller, C., H.K. Gershenfeld, C.G. Lobe, C.Y. Okada, R.C. Bleackley, and I.L. Weissman. 1988. A high proportion of T lymphocytes that infiltrate H-2 incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor. J. Exp. Med. 167:1124-1136.
21. Klinman, D.M., and T.B. Nutman. 1994. ELISPOT assay to detect cytokine-secreting murine and human cells. In Current Protocols in Immunology. Vol. 1. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley and Sons, Inc., New York. 6.19.1-6.19.8.
22. Castano, L., and G.S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8:647-679.
23. Hu, Y., Y. Nakagawa, K.R. Purushotham, and M.G. Humphreys Beher. 1992. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263:607-614.
24. Held, W., H.R. MacDonald, I.L. Weissman, M.W. Hess, and C. Mueller. 1990. Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natll. Acad. Sci. USA. 87: 2239-2243.
25. Fox, R.I., H. Kang, D. Ando, J. Abrams, and E. Pisa. 1994. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J. Immunol. 152:5532-5539.
26. Faveeuw, C., M.C. Gagnerault, and F. Lepault. 1994. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonohese diabetic mice. J. Immunol. 152:5969-5978.
27. Yang, X.D., S.A. Michie, R. Tisch, N. Karin, L. Steinmann, and H.O. McDevitt. 1994. A predominant role of integrin α4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA. 91:12604-12608.
28. Kolb, H., V. Kolb-Bachofen, and O. Rocp. 1995. Autoimmune versus inflammatory type I diabetes: a controversy? Immunol. Today. 16:170-172.